--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--
US Stock MarketDetailed Quotes
ACHL Achilles Therapeutics
- 0.760
- -0.014-1.86%
Close Apr 26 16:00 ET
- 0.760
- 0.0000.00%
Post 16:00 ET
30.31MMarket Cap-436P/E (TTM)
0.799High0.740Low382.13KVolume0.761Open0.774Pre Close288.93KTurnover1.77%Turnover RatioLossP/E (Static)39.88MShares1.76052wk High0.21P/B16.43MFloat Cap0.74052wk Low--Dividend TTM21.62MShs Float18.948Historical High--Div YieldTTM7.65%Amplitude0.740Historical Low0.756Avg Price1Lot Size
Achilles Therapeutics Key Stats
Achilles Therapeutics Earnings Date
Currency: USD
Period
Q4 FY2023 Earnings
--
Revenue(YoY)
0.00
0.00%EPS(YoY)
-0.46
+25.81%Analyst Rating
Apr 4, 2024
Achilles Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Achilles Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg